(Q48160125)

English

Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17517949

Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17517949

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Subsai Kongsaengdao

1

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17517949

Kanoksri Samintarapanya

2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17517949

Kanokporn Oranratnachai

3

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17517949

Wantana Prapakarn

4

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17517949

Chatchawann Apichartpiyakul

5

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17517949

publication date

21 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17517949

Journal of the International Association of Providers of AIDS Care

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17517949

7

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17517949

1

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17517949

11-16

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17517949

Neurological complications in AIDS patients: the 1-year retrospective study in Chiang Mai University, Thailand

1 reference

https://api.crossref.org/works/10.1177%2F1545109707301244

21 January 2018

Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1177%2F1545109707301244

21 January 2018

Recently acquired Toxoplasma gondii infection, Brazil

1 reference

https://api.crossref.org/works/10.1177%2F1545109707301244

21 January 2018

Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1177%2F1545109707301244

21 January 2018

Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1177%2F1545109707301244

21 January 2018

Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Rec

1 reference

https://api.crossref.org/works/10.1177%2F1545109707301244

21 January 2018

Treatment of acute toxoplasmosis with intravenous clindamycin. The California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1177%2F1545109707301244

21 January 2018

Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS.

1 reference

https://api.crossref.org/works/10.1177%2F1545109707301244

21 January 2018

Prevalence, Associated Factors, and Prognostic Determinants of AIDS‐Related Toxoplasmic Encephalitis in the Era of Advanced Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1177%2F1545109707301244

21 January 2018

Identifiers

10.1177/1545109707301244

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17517949

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17517949

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48160125&oldid=2188015451"